GlaxoSmithKline (GLAXO) | Stock Overview & Key Data
GlaxoSmithKline Performance Comparison
Stock Range
Today's Range
Low: ₹2,686.00
High: ₹2,759.50
on October 3, 2025
52 Week Range
Low: ₹1,921.00
High: ₹3,515.70
on February 3, 2025
on June 5, 2025
All-Time High: ₹3,872.00 on March 28, 2016
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR458.6B
EPS
56.12
P/E Ratio (TTM)
47.39
Forward P/E
45.94
P/B Ratio
23.09
PEG Ratio
3.81
Div. Yield
1.65%
ROE
47.54%
Beta
0.044
Debt to Equity
0.51
Financial Highlights
Profitability
Gross Margin
64.27%
Operating Margin
29.27%
Profit Margin
25.41%
Returns and Earnings
Return on Assets (TTM)
22.58%
Return on Equity (TTM)
47.54%
EBITDA
INR12.8B
Net Income (TTM)
INR9.5B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR220.76
Quarterly Revenue Growth (YoY)
-1.20%
Quarterly Earnings Growth (YoY)
12.40%
Dividend Information
Last 12-Month Dividend
₹54.00
Current Dividend Yield
1.65%
3-Year Average Dividend Yield
1.86%
3-Year Average Annual Dividend
₹59.33
3-Year Total Dividends
₹178.00
Ex-Dividend Date
May 30, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| GlaxoSmithKline GLAXO | 458.57B Large-cap | -1.79% | -3.96% | -19.57% | -3.58% | 20.84% | -1.52% | 93.34% | 80.13% |
| Pfizer PFIZER | 231.58B Large-cap | 2.92% | 0.31% | -9.61% | 27.62% | -2.95% | -8.29% | 16.04% | 2.57% |
| Sanofi India Limited SANOFI | 110.69B Mid-cap | -5.70% | -7.96% | -24.04% | -19.50% | -22.71% | -31.49% | -20.52% | -45.48% |
| Sanofi Consumer SANOFICONR | 108.89B Mid-cap | -5.13% | -6.70% | -12.40% | -1.24% | -3.25% | -4.79% | -3.15% | -3.15% |
| Marksans Pharma MARKSANS | 77.07B Mid-cap | -2.00% | -0.42% | -35.52% | -24.91% | -45.29% | -42.49% | 252.74% | 211.24% |
| Senores SENORES | 32.95B Small-cap | -4.06% | -1.93% | 18.10% | 22.01% | 20.44% | 20.06% | 20.06% | 20.06% |
Ownership & Short Interest
Insider Ownership
75.63%
Institutional Ownership
8.60%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
98K
Average 90-Day Volume
95K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GLAXO's 52-week high and low?
- In the last 52 weeks, GlaxoSmithKline reached a high of ₹3,515.70 (on June 5, 2025) and a low of ₹1,921.00 (on February 3, 2025).
- What is the market cap and P/E ratio for GLAXO?
- Curious about GlaxoSmithKline's size and valuation? Its market capitalization stands at 458.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is 47.39, and the forward P/E (looking ahead) is 45.94.
- Does GLAXO pay dividends? If so, what's the yield?
- Yes, GlaxoSmithKline is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.65%, and the company has paid an average of ₹59.33 per share annually over the past 3 years.
- Who are GlaxoSmithKline's main competitors or similar companies to consider before investing?
When looking at GlaxoSmithKline, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Pfizer
PFIZER231.58B Healthcare Drug Manufacturers - General -8.29% 16.04% Sanofi India Limited
SANOFI110.69B Healthcare Drug Manufacturers - General -31.49% -20.52% Sanofi Consumer
SANOFICONR108.89B Healthcare Drug Manufacturers - General -4.79% -3.15% Marksans Pharma
MARKSANS77.07B Healthcare Drug Manufacturers - General -42.49% 252.74% Senores
SENORES32.95B Healthcare Drug Manufacturers - General 20.06% 20.06% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for GlaxoSmithKline Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of GlaxoSmithKline's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 47.54%, the Debt to Equity ratio from the most recent quarter is 0.51, and its Gross Profit Margin stands at 64.27%.
- What is the recent revenue and earnings growth for GLAXO?
- Looking at GlaxoSmithKline's growth, its revenue over the trailing twelve months (TTM) was INR37B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.20%, and quarterly earnings saw a YoY growth of 12.40%.
- How much of GLAXO stock is held by insiders and institutions?
- Wondering who owns GlaxoSmithKline stock? Company insiders (like executives and directors) hold about 75.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.